The Humanized Mouse Platform of Alfa Cytology Facilitates Preclinical Studies of Immunotherapy Drugs
Summary
Alfa Cytology is highlighting its Hu-Immune humanized mouse platform for preclinical immunotherapy research. The service uses huPBMC and huHSC models to create more human-relevant experimental conditions for evaluating drug efficacy and immune mechanisms. It also supports tumor model testing, immune microenvironment analysis, and in vivo drug distribution studies. The company positions the platform as a way to improve data reliability and speed up preclinical validation for immunotherapy candidates.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected